Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2023-02-21 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-23-011455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2021-11-16 | BBIO | Cook Jennifer E. | Dir | M - OptEx | — | +3,576 | 7,152 | +100% | — |
| D | 2023-02-21 | 2021-11-16 | BBIO | Cook Jennifer E. | Dir | M - OptEx | $0.00 | -3,576 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | M | A | 3,576 | — | 7,152 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2021-11-16 | M | D | 3,576 | $0.00 | 0 | D | — · — to — | 3,576 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% vested on November 16, 2021. |